CN105753945B - A kind of link peptide and its application - Google Patents
A kind of link peptide and its application Download PDFInfo
- Publication number
- CN105753945B CN105753945B CN201410769966.1A CN201410769966A CN105753945B CN 105753945 B CN105753945 B CN 105753945B CN 201410769966 A CN201410769966 A CN 201410769966A CN 105753945 B CN105753945 B CN 105753945B
- Authority
- CN
- China
- Prior art keywords
- mbp
- link peptide
- heparinase
- fusion
- chondrosulphatase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
The invention discloses a kind of link peptide and its applications.Link peptide of the invention is mainly used in preparation MBP fusion polysaceharide lyase, and in particular to MBP fusion heparinase I, II, III, MBP fusion chondrosulphatase B, AC.In MBP amalgamation and expression system, MBP hydrotropy is improved by the link peptide application, helps folding, increase the activity and thermal stability of target protein, the final fermentation enzyme activity obtained in Escherichia coli tentatively reaches the horizontal and MBP fusion heparinase I with outstanding thermal stability of industrial application, II, III, MBP fusion chondrosulphatase B, AC.
Description
Technical field
The invention belongs to genetic engineerings and field of fermentation engineering, and in particular to a kind of link peptide and its application.
Background technique
Heparinase (heparinase) is that one kind may act on heparin (heparin) or Heparan sulfate (heparin
Sulfate) the polysaceharide lyase of the glycosidic bond of molecule.The heparinase type being currently known has I, II, III 3 kind, is from gram
It is found in negative bar bacterium Flavobacterium heparinum.Three kinds of zymolyte specificity and the mode of action are different, and Heparinase I substrate is
Heparin, the substrate of Heparinase I I are heparin and Heparan sulfate, and the substrate of Heparinase I II is Heparan sulfate.Heparinase
There is important application value in scientific research and application field.
Chondrosulphatase (chondroitinase or chondroitin sulfaeyase, abbreviation ChSase) is a kind of
The glycosaminoglycans such as chondroitin sulfate, chondroitin, hyaluronic acid can be degraded to unsaturated disaccharides.ChSase includes chondroitin sulfate
Enzyme B, chondrosulphatase AC.In recent years, ChSase as it is a kind of study protein in body glycan structure and function tool with
And the attention of people is increasingly subject to as a kind of novel medicinal enzyme.
In view of the significant application value of heparinase, chondrosulphatase, researcher is very early to it in microflora
In recombinant expression studied, but poor effect, main technical bottleneck are to be difficult to realize heparinase, chondrosulphatase
Soluble-expression, while its catalytic activity and thermal stability are relatively low, require that there are also very big distances apart from industrial application.
The soluble-expression effect of heparinase, chondrosulphatase can be improved in fusion protein strategy.In structure biology, pass through
Construction of fusion protein increases the expression of soluble protein and facilitates purifying (the Hongyuan M. A self-cleavable of albumen
sortase fusion for one-step purification of free recombinant proteins.
Protein Expression and Purification ,2004,37(1):253-263;With Sun-ok K, Young I
L. High-level expression and simple purification of recombinant human
Insulin-like growth factor I. Journal of Biotechnology, 1996,48:97-105.)
As a kind of effective method.Link peptide is much larger than enzyme sheet as the key element in fusion protein strategy, changeability
Body, and significant impact (Cahalon L, Lider O, Schor H, et.al. Heparin can be generated to fusion enzyme performance
disaccharides inhibit tumor necrosis factor-α production by macrophages and
arrest immue inflammation in rodents. Int. Immunol.,1997,9:1517-1522;And Kakkar
A. Low- and ultra-low-molecular-weight heparins. Best Practice & Research
Clinical Haematology, 2004,17 (1): 77-87.).Link peptide with appropriate length and hard and soft degree can be two
A enzyme (structural domain) is properly separated from, so as to avoid different structure and interfering with each other in folding, catalytic process.Although even
Connect peptide to have a major impact the function of fusion protein, but regrettably, so far in succession peptide in heparinase, chondroitin sulfate
The research of the polysaceharide lyases such as enzyme is less, and existing relevant enzyme requires also biggish distance apart from industrial application.
Summary of the invention
The present invention provides a kind of link peptide, and sequence is shown in SEQ ID NO.1 or SEQ ID NO.2.
The link peptide is preparing MBP(maltose-binding protein) fusion polysaceharide lyase in application.
Link peptide prepare MBP fusion polysaceharide lyase in process it is as follows:
(1) permutation and combination based on rigid flexible amino acid sequence units designs link peptide L1, L2, nucleotide sequence point
It Wei not SEQ ID NO.1, SEQ ID NO.2;
(2) by MBP sequence and polysaccharide in sequence SEQ ID NO.1 or SEQ ID NO.2 insertion MBP fusion polysaceharide lyase
Between lyase gene sequence, obtains the MBP containing the connection peptide sequence and merge polysaceharide lyase expression vector, then carry out
MBP merges the expression of polysaceharide lyase, obtains the MBP fusion polysaceharide lyase containing the link peptide.
The polysaceharide lyase gene is derived from Flavobacterium heparinum.
Polysaceharide lyase in the polysaceharide lyase gene is heparinase or chondroitin sulfate in Flavobacterium heparinum
Enzyme, wherein heparinase includes heparinase I, heparinaseⅡ, heparinase III, and chondrosulphatase includes chondrosulphatase B, sulfuric acid
Chondroitinase AC.
A kind of MBP fusion heparinase containing link peptide SEQ ID NO.1, including MBP fusion heparinase I, MBP merge liver
Plain enzyme II, MBP fusion heparinase III, nucleotide sequence are respectively SEQ ID NO.3, SEQ ID NO.4, SEQ in sequence table
ID NO.5。
A kind of MBP fusion chondrosulphatase containing link peptide SEQ ID NO.1, including MBP merge chondroitin sulfate
Enzyme B, MBP merge chondrosulphatase AC, and nucleotide sequence is respectively SEQ ID NO.6 in sequence table, SEQ ID NO.7.
A kind of MBP fusion heparinase containing link peptide SEQ ID NO.2, including MBP fusion heparinase I, MBP merge liver
Plain enzyme II, MBP fusion heparinase III, nucleotide sequence are respectively SEQ ID NO.8, SEQ ID NO.9, SEQ in sequence table
ID NO.10。
A kind of MBP fusion chondrosulphatase containing link peptide SEQ ID NO.2, including MBP merge chondroitin sulfate
Enzyme B, MBP merge chondrosulphatase AC, and nucleotide sequence is respectively SEQ ID NO.11, SEQ ID in sequence table
NO.12。
The present invention designs a kind of link peptide, the molecular modification for recombinant protein.Polysaccharide in Flavobacterium heparinum is split
Enzyme is solved, using the method for MBP amalgamation and expression, the catalytic activity for improving MBP fusion enzyme is redesigned and replaced to the link peptide
And thermal stability.In MBP amalgamation and expression system, MBP hydrotropy is improved by the redesign and replacement of the link peptide, helps folding
Folded, increase target protein activity and thermal stability.
The present invention is redesigned and is replaced to the MBP link peptide for merging polysaceharide lyase by the means of genetic engineering
It changes, the final fermentation enzyme activity obtained in Escherichia coli tentatively reaches industrial application level and the MBP with outstanding thermal stability
Fusion heparinase I, II, III, chondrosulphatase B, AC.
Detailed description of the invention
Fig. 1 MBP fusion heparinase I link peptide replacement front and back expression effect characterization,
Wherein T:Total Protein indicates that total protein sample, S:Soluble Protein indicate soluble protein,
I:Insoluble Protein indicates insoluble albumen.
II link peptide of Fig. 2 MBP fusion heparinase replacement front and back expression effect characterization,
Wherein T:Total Protein indicates that total protein sample, S:Soluble Protein indicate soluble protein,
I:Insoluble Protein indicates insoluble albumen.
III link peptide of Fig. 3 MBP fusion heparinase replacement front and back expression effect characterization,
Wherein T:Total Protein indicates that total protein sample, S:Soluble Protein indicate soluble protein,
I:Insoluble Protein indicates insoluble albumen.
Fig. 4 MBP merges chondrosulphatase B link peptide replacement front and back expression effect characterization,
Wherein T:Total Protein indicates that total protein sample, S:Soluble Protein indicate soluble protein,
I:Insoluble Protein, indicates insoluble albumen, and P is the purifying protein through MBPTrap HP mono- after purification.
Fig. 5 MBP merges chondrosulphatase AC link peptide replacement front and back expression effect characterization,
Wherein T:Total Protein indicates that total protein sample, S:Soluble Protein indicate soluble protein,
I:Insoluble Protein, indicates insoluble albumen, and P is the purifying protein through MBPTrap HP mono- after purification.
Fig. 6 MBP fusion heparinase I link peptide replacement front and back thermal stability compares.
II link peptide of Fig. 7 MBP fusion heparinase replacement front and back thermal stability compares.
Fig. 8 MBP fusion heparinase III link peptide replacement front and back thermal stability compares.
Fig. 9 MBP fusion chondrosulphatase B link peptide replacement front and back thermal stability compares.
Figure 10 MBP fusion chondrosulphatase AC link peptide replacement front and back thermal stability compares.
The degradation of substrates mechanism parsing of Figure 11 MBP fusion heparinase I link peptide replacement front and back: product aggregate analysis,
Wherein, 11A Composition distribution;11B UV detector.
The degradation of substrates mechanism parsing of Figure 12 MBP fusion heparinase I link peptide replacement front and back: disaccharide component analysis,
Wherein, 12A:MBP-HepA;12B:MBP-R-HepA;12C:MBP-F-HepA.
The degradation of substrates mechanism parsing of II link peptide of Figure 13 MBP fusion heparinase replacement front and back: product aggregate analysis,
Wherein, 13A Composition distribution;13B UV detector.
The degradation of substrates mechanism parsing of II link peptide of Figure 14 MBP fusion heparinase replacement front and back: disaccharide component analysis,
Wherein, 14A:MBP-HepA;14B:MBP-R-HepA;14C:MBP-F-HepA.
The degradation of substrates mechanism parsing of III link peptide of Figure 15 MBP fusion heparinase replacement front and back: product aggregate analysis,
Wherein, 15A Composition distribution;15B UV detector.
The degradation of substrates mechanism parsing of II link peptide of Figure 16 MBP fusion heparinase replacement front and back: disaccharide component analysis,
Wherein, 16A:MBP-HepA;16B:MBP-R-HepA;16C:MBP-F-HepA.
Specific embodiment
The present invention is illustrated combined with specific embodiments below.
Design, the MBP of link peptide containing target fusion polysaceharide lyase vector construction and the expression of 1 link peptide of embodiment
1, the design of link peptide
(1) origin of link peptide:
Due to the length and property (hard and soft degree) property that fusion protein can be significantly affected of link peptide, this is mainly due to
The space length and positional relationship in fusion protein between two elements are changed, mutual active force and space bit are caused
Resistance is different, and then different degrees of influence is caused to the structure of albumen, and the biological function for finally influencing two elements is especially
Biological function as main catalyzing enzyme.Influence of the length for the property of fusion protein is the most significant, however also because
This reason, the variation for being difficult prediction length influence fusion protein in what degree, so applying upper desired reason for us
Property design fusion protein it is very unfavorable.If on the basis of appropriate length, by the hard and soft degree of link peptide come to fusion protein
Space length between two elements and positional relationship carry out " fine tuning ", then may be implemented to fusion protein physicochemical property by
Step section, we, can be according to the property of different link peptides design institute on the basis of fully understanding to target protein in this way
The fusion protein needed, to obtain the fusion protein of different physical and chemical attributes.
Based on above-mentioned general idea, we just include 5 amino acid the flexible peptide unit F(in nature) and just
Property peptide unit R(include 5 amino acid) as we design primary element, choose FFFFF and RRRRR be study link peptide
Length unit, on the basis of 5 link peptide element lengths, the hard and soft unit of opposite is replaced to be connected with heterozygosis, from
And a series of heterozygosis connection peptide library that hard and soft degree have gradual change law is obtained, melted by replacing these link peptides to different
In hop protein, we very light can must obtain required fusion protein.
(2) design software: " design " of link peptide is used in fact or based on rigid, flexible unit permutation and combination
DiscoverStudio software carries out molecular simulation to the link peptide conformation of different permutation and combination, passes through subsequent experimental result
It is compared, corrects with the analog result, obtain the link peptide for really being able to be adjusted on space length and positional relationship
Candidate library and link peptide basis for selecting.It is final to obtain link peptide L1, L2, nucleotide sequence be respectively SEQ ID NO.1 or
Shown in SEQ ID NO.2.
2, the MBP of link peptide containing target merges polysaceharide lyase vector construction
The MBP of link peptide containing target merges polysaceharide lyase vector construction step: expressing heparinase I fusion protein carry respectively
Body pMal-hepA(patent No. CN1699424A), the heparinaseⅡ fusion protein expression vector pMal-hepB(patent No.
CN101942024A), heparinase III fusion protein expression vector pMal-hepC(patent No. CN101942025A), chondroitin sulfate
Plain enzyme B fusion protein expression vector pMAL-ChSase B(patent No. CN103103173A), chondrosulphatase AC fusion protein
Expression vector pMAL-ChSase AC(patent No. CN103103174A) respectively with " NdeI+HindIII ", " NdeI+
PstI ", " NdeI+PstI ", " NdeI+HindIII ", " NdeI+EcoRI " carry out digestion, then respectively and with identical
Link peptide L1, L2 of the first end restriction enzyme site, is attached with T4 ligase, and the fusion polysaccharide for obtaining the link peptide containing target is split
Solve zymophore.
Expression, purifying and the enzyme activity analysis of 2 target protein of embodiment
The fusion polysaceharide lyase carrier expression of target link peptide will be contained: the fusion polysaccharide cracking of link peptide containing target will be built
Zymophore plasmid converts Escherichia coli respectively, and conversion has the bacterial strain of recombinant plasmid in the LB training containing 100ug/mL ampicillin
It supports after shaking overnight incubation (37 DEG C, 180rpm, 14-16h) in base, is inoculated into LB/M9YE fermentation training according to the ratio of 1:100
It supports in base, 37 DEG C, 180rpm shakes to logarithmic growth phase, goes to 200rpm, 15 DEG C of low temperature induction culture 20- after IPTG is added
22h。
Protein extraction and purification process: will be delayed after the Escherichia coli fermentation bacterium solution collection bacterium of 100ml mesh with 20ml protein extraction
Fliud flushing is resuspended, ultrasonication thallus, and 4 DEG C of breakdown products, 10000rpm is centrifuged 30 minutes, collects supernatant, filters through 0.22 μm of film,
Slowly (1mL/min) passes through MBPTrap the HP(1 ml, 5ml of GE Healthcare) affinity column, it is in charge of collection eluent, examines
Survey each tubulin concentration, SDS-PAGE electrophoresis detection purification effect.Protein purification is enterprising in AKTA plus protein purification system
Row, it is whole that the polysaccharide cracking MBP fusion protein purified is operated in 4 DEG C of low temperature chromatography cabinets.
Enzyme activity detection uses the optical absorption method of 232nm, the definition of the enzyme activity of 1IU be 30 DEG C of 1um generated per minute not
The reaction effect of saturated bond.The GOLDS54 ultraviolet-uisible spectrophotometer of concrete operations Prism Optical Technology Co is surveyed
Determine absorbance versus time curve.Scanning wavelength is set to 232 nm, and the time is 3 min.Take reaction buffer (20 mM
Tris, 200 mM NaCl, after completely dissolution with the salt acid for adjusting pH value of 1 M to 7.4,4 DEG C of preservations) and a certain amount of enzyme solutions
The totally 1000 specific ratios of μ L(need to be according to the big minor adjustment of enzyme solution vigor), 500 μ L substrate solutions (17 mM Tris, 44 mM
NaCl, 3.5 mM CaCl2,25g/L substrates, with the salt acid for adjusting pH value of 1 M to 7.0,4 DEG C of preservations after being sufficiently stirred.) its
In, I, II, III substrate of MBP fusion heparinase: 25 g/L heparin sodiums --- the enzyme activity for MBP fusion heparinase I or II is surveyed
It is fixed, 25 g/L Heparan sulfate sodium --- the enzyme activity determinations for Heparinase I II;Chondrosulphatase B, AC substrate: 25 g/
L chondroitin sulfate.Then spectrophotometer is immediately placed in after quartz colorimetric utensil, mixing to start to scan, survey the unit time in
The absorbance change △ A232 of 232nm.Extinction coefficient epsilon=3800 M-1 cm-1.Enzyme activity is calculated according to Beer law.
1, MBP fusion heparinase I
Heparinase I fusion protein (patent No. CN1699424A) is named as MBP-HepA as control, replacement link peptide 1
MBP fusion heparinase I is named as MBP-R-HepA;The MBP fusion heparinase I of replacement link peptide 2 is named as MBP-F-HepA.
MBP fusion heparinase I after purification, carries out SDS-PAGE electrophoresis, the result is shown in Figure 1.
It is analyzed using 5.0 software of Bandscan, the trend of replacement front and back target protein soluble-expression has indifference, target
The specific gravity that albumen accounts for total protein increased, and specific gravity is increased to 61% from 48% or so.
It is that analysis measurement is carried out with supernatant soluble protein S component when analyzing enzyme activity.
The shake flask fermentation total enzyme activity measurement of 1 MBP fusion heparinase I link peptide of table replacement front and back
After link peptide is replaced, fermentation total enzyme activity of the MBP fusion heparinase I in shaking flask reaches 41230.18 IU/L, is
It is currently known peak.
(2) MBP fusion heparinase II
HeparinaseⅡ fusion protein (patent No. CN101942024A) is named as MBP-HepB as control;Replacement connection
The MBP fusion heparinase II of peptide 1 is named as MBP-R-HepB;The MBP fusion heparinase I of replacement link peptide 2 is named as MBP-F-
HepB。
MBP fusion heparinase II after purification, carries out SDS-PAGE electrophoresis, as a result sees Fig. 2.
After link peptide replacement, the specific gravity that MBP-R-HepB target protein accounts for total protein increases by 1 times, MBP-F-HepB target egg
The white specific gravity no significant difference for accounting for total protein.
The shake flask fermentation total enzyme activity measurement of 2 MBP fusion heparinase of table, II link peptide replacement front and back
After link peptide is replaced, fermentation total enzyme activity of the MBP fusion heparinase II in shaking flask reaches 3674.82 IU/L, is
It is currently known peak.
(3) MBP fusion heparinase III
Heparinase III fusion protein (patent No. CN101942025A) is named as MBP-HepC as control;Replacement connection
The MBP fusion heparinase II of peptide 1 is named as MBP-R-HepC;The MBP fusion heparinase I of replacement link peptide 2 is named as MBP-F-
HepC。
MBP fusion heparinase III after purification, carries out SDS-PAGE electrophoresis, as a result sees Fig. 3.
After link peptide replacement, the specific gravity that MBP-R-HepC target protein accounts for total protein increases by 1.5 times, MBP-F-HepB target
The specific gravity that albumen accounts for total protein increases by 1 times.
The shake flask fermentation total enzyme activity measurement of 3 heparinase III link peptide of table replacement front and back
After link peptide is replaced, fermentation total enzyme activity of the MBP fusion heparinase III in shaking flask reaches 12934.34 IU/L,
It is to be currently known peak.
(4) MBP merges chondrosulphatase B
MBP merges chondrosulphatase B after purification, carries out SDS-PAGE electrophoresis, and MBP merges chondrosulphatase B connection
Peptide replacement front and back expression effect is shown in Fig. 4.
After link peptide replacement, the specific gravity that MBP-R-HepB target protein accounts for total protein increases by 1 times, MBP-F-HepB target egg
The white specific gravity no significant difference for accounting for total protein.
4 MBP of table merges the shake flask fermentation total enzyme activity measurement of chondrosulphatase B link peptide replacement front and back
After link peptide is replaced, MBP merges fermentation total enzyme activity of the chondrosulphatase B in shaking flask and reaches 24206.2IU/
L is to be currently known peak.
(5) MBP merges chondrosulphatase AC
MBP merges chondrosulphatase AC after purification, carries out SDS-PAGE electrophoresis, and MBP merges chondrosulphatase B connection
Peptide replacement front and back expression effect is shown in Fig. 5.
After link peptide replacement, the specific gravity that MBP-R-HepB target protein accounts for total protein increases by 2.5 times, MBP-F-HepB target
The specific gravity that albumen accounts for total protein increases by 1.5 times.
5 MBP of table merges the shake flask fermentation total enzyme activity measurement of chondrosulphatase AC link peptide replacement front and back
After link peptide is replaced, MBP merges fermentation total enzyme activity of the chondrosulphatase AC enzyme in shaking flask and reaches
22162IU/L is to be currently known peak.
4 link peptide of embodiment replacement front and back MBP merges polysaceharide lyase thermal stability analysis
Enzyme activity of the enzymatic activity as time point for 0 moment will be measured immediately after protein purification, by pure enzyme as detection temperature
Middle water-bath, choosing different time points is sampled survey enzyme activity, is compared with 0 moment enzyme activity, when calculating the moment relative to 0
Carve the percentage of enzyme activity.Persistently the operation to enzyme activity is down to lower unknown, is thus obtained a series of warm bath time points and is remained
These points are attached up to the inactivation curve of the enzyme at such a temperature by the corresponding relationship point of remaining enzyme activity, also can be to this
The stability of enzyme at such a temperature is evaluated.
Enzyme heat stability is analyzed after the shake flask fermentation of 1.MBP fusion heparinase I link peptide replacement front and back
After link peptide is replaced, enzyme activity half-life period of the MBP fusion heparinase I at 30 DEG C is increased to the left side 35min from 10min
As a result Fig. 6 is seen on the right side.
2, enzyme heat stability is analyzed after the shake flask fermentation of II link peptide of MBP fusion heparinase replacement front and back
After link peptide is replaced, enzyme activity half-life period of the MBP fusion heparinase II at 30 DEG C is increased to the left side 250h from 80h
As a result Fig. 7 is seen on the right side.
3, enzyme heat stability is analyzed after the shake flask fermentation of III link peptide of MBP fusion heparinase replacement front and back
After link peptide is replaced, enzyme activity half-life period of the MBP fusion heparinase III at 30 DEG C from 60h be increased to 250h with
On, as a result see Fig. 8.
4, enzyme heat stability is analyzed after MBP merges chondrosulphatase B link peptide replacement front and back shake flask fermentation
After link peptide is replaced, MBP fusion chondrosulphatase B thermal stability measuring the results are shown in Table 6;MBP fusion
Enzyme activity half-life period of the chondrosulphatase B at 30 DEG C from the left and right 500h or more is increased to for 24 hours, as a result sees Fig. 9.
6 MBP of table merges chondrosulphatase B stability contrast table
5, enzyme heat stability is analyzed after MBP merges chondrosulphatase AC link peptide replacement front and back shake flask fermentation
After link peptide is replaced, MBP fusion chondrosulphatase AC thermal stability measuring the results are shown in Table 7;MBP fusion
Enzyme activity half-life period of the chondrosulphatase AC under 30 degree is increased to 100h or so, the result is shown in Figure 10 from 8.3h.
7 MBP of table merges chondrosulphatase AC stability contrast table
Influence of 5 link peptide of the embodiment replacement front and back MBP fusion polysaceharide lyase to degradation of substrates mechanism
Choosing MBP fusion polysaceharide lyase is research object, passes through Bacillus coli expression and protein extraction, purifying
Operating procedure obtains the sterling of the enzyme.Corresponding substrate is chosen, pure enzyme is added in substrate, carries out bottom under suitable conditions
Object degradation reaction, using the absorbance value under 232nm as Testing index, as reaction end when no longer being changed using the absorption value.It will be anti-
Product is answered to pass through the impurity such as the albumen a series of purification steps removals the inside such as be centrifuged, take supernatant, filtering, by the oligosaccharides group of collection
Divide the analysis for carrying out HPLC, obtains the map of the enzyme catabolite, different control samples is chosen according to different purposes, such as
Compare link peptide replacement front and back catabolite difference just replaced using link peptide before fusion enzyme catabolite as compare.
Specific relatively parameter includes appearance time and peak area, and only the two numerical value are almost the same, can judge two fusion enzymes
It is whether identical to the degradation mechanism of substrate.The detection type of HPLC mainly includes the spectrum analysis and drop of catabolite principal component
The spectrum analysis of disaccharide component in product is solved, Detection wavelength used in the two detections is different, therefore in order to rigorous
Property, need the two wavelength to be all measured.
1, MBP fusion heparinase I link peptide replacement front and back is to degradation of substrates mechanism impact analysis
Component after thoroughly degrading to the MBP fusion heparinase I of link peptide replacement front and back to heparin substrate is analyzed, and is tied
Fruit such as Figure 11.Figure 12 is shown in the analysis of catabolite disaccharide component.
2, II link peptide of MBP fusion heparinase replacement front and back is to degradation of substrates mechanism impact analysis
Component after thoroughly degrading to the MBP fusion heparinase II of link peptide replacement front and back to heparin substrate is analyzed,
As a result such as Figure 13.Figure 14 is shown in the analysis of catabolite disaccharide component.
3, III link peptide of MBP fusion heparinase replacement front and back is to degradation of substrates mechanism impact analysis
Component after thoroughly degrading to the MBP fusion heparinase II of link peptide replacement front and back to heparin substrate is analyzed,
As a result such as Figure 15.Figure 16 is shown in the analysis of catabolite disaccharide component.
From the foregoing, it will be observed that by HPLC means in overall degradation product and product disaccharide component analysis shows, MBP melts
Close that heparinase I, MBP fusion heparinase II, the replacement of link peptide does not influence heparinase to the drop of substrate in MBP fusion heparinase III
Solution mechanism.
<110>Wuxi Application Technology Research Institute of Tsinghua University
<120>a kind of link peptide and its application
<160> 12
<210> 1
<211> 75
<212> DNA
<213>artificial sequence
<220>
<223>
<400> 1
gaggctgccg caaaggaagc ggcagcgaaa gaggcggccg caaaagaggc agcggcgaaa 60
gaagctgcgg ccaag 75
<210> 2
<211> 76
<212> DNA
<213>artificial sequence
<220>
<223>
<400> 2
ggtggtggcg gcagcggtgg cggcggtagc ggcggtggtg gatccggtgg cggtggttct 60
ggtggtggtg gcagcc 76
<210> 3
<211> 2268
<212> DNA
<213>artificial sequence
<220>
<223>
<400> 3
atgaaaatcg aagaaggtaa actggtaatc tggattaacg gcgataaagg ctataacggt 60
ctcgctgaag tcggtaagaa attcgagaaa gataccggaa ttaaagtcac cgttgagcat 120
ccggataaac tggaagagaa attcccacag gttgcggcaa ctggcgatgg ccctgacatt 180
atcttctggg cacacgaccg ctttggtggc tacgctcaat ctggcctgtt ggctgaaatc 240
accccggaca aagcgttcca ggacaagctg tatccgttta cctgggatgc cgtacgttac 300
aacggcaagc tgattgctta cccgatcgct gttgaagcgt tatcgctgat ttataacaaa 360
gatctgctgc cgaacccgcc aaaaacctgg gaagagatcc cggcgctgga taaagaactg 420
aaagcgaaag gtaagagcgc gctgatgttc aacctgcaag aaccgtactt cacctggccg 480
ctgattgctg ctgacggggg ttatgcgttc aagtatgaaa acggcaagta cgacattaaa 540
gacgtgggcg tggataacgc tggcgcgaaa gcgggtctga ccttcctggt tgacctgatt 600
aaaaacaaac acatgaatgc agacaccgat tactccatcg cagaagctgc ctttaataaa 660
ggcgaaacag cgatgaccat caacggcccg tgggcatggt ccaacatcga caccagcaaa 720
gtgaattatg gtgtaacggt actgccgacc ttcaagggtc aaccatccaa accgttcgtt 780
ggcgtgctga gcgcaggtat taacgccgcc agtccgaaca aagagctggc aaaagagttc 840
ctcgaaaact atctgctgac tgatgaaggt ctggaagcgg ttaataaaga caaaccgctg 900
ggtgccgtag cgctgaagtc ttacgaggaa gagttggcga aagatccacg tattgccgcc 960
actatggaaa acgcccagaa aggtgaaatc atgccgaaca tcccgcagat gtccgctttc 1020
tggtatgccg tgcgtactgc ggtgatcaac gccgccagcg gtcgtcagac tgtcgatgaa 1080
gccctgaaag acgcgcagac tgaggctgcc gcaaaggaag cggcagcgaa agaggcggcc 1140
gcaaaagagg cagcggcgaa agaagctgcg gccaagcagc aaaaaaaatc cggtaacatc 1200
ccttaccggg taaatgtgca ggccgacagt gctaagcaga gcgagattat tgacaacaaa 1260
tgggtggcag taggcatcaa taaaccttat gcattacaat atgacgataa actgcgcttt 1320
aatggaaaac catcctatcg ctttgagctt aaagccgaag acaattcgct tgaaggttat 1380
gctgcaggag aaacaaaggg ccgtatagaa ttgtcgtaca gctatgcaac caccaatgat 1440
tttaagaaat ttcccccaag cgtataccaa aatgcgcaaa agctaaaaac cgtttatcat 1500
tacggcaaag ggatttgtga acaggggagc tcccgcagct ataccttttc agtgtacata 1560
ccctcctcct tccccgacaa tgcgactact atttttgccc aatggcatgg tgcacccagc 1620
agaacgcttg tagctacacc agagggagaa attaaaacac tgagcataga agagtttttg 1680
gccttatacg accgcatgat cttcaaaaaa aatatcgccc atgataaagt tgaaaaaaaa 1740
gataaggacg gaaaaattac ttatgtagcc ggaaagccaa atggctggaa ggtagaacaa 1800
ggtggttatc caccgctggc ctttggtttt tctaaagggt atttttacat caaggcaaac 1860
tccgaccggc agtggcttac cgacaaagcc gaccgtaaca atgccaatcc cgagaatagt 1920
gaagtaatga agccctattc ctcggaatac aaaacttcta ccattgccta taaaatgccc 1980
tttgcccagt tccctaaaga ttgctggatt acttttgatg tcgccataga ctggacgaaa 2040
tatggaaaag aggccaatac aattttgaaa cccggtaagc tggatgtgat gatgacttat 2100
accaagaata agaaaccaca aaaagcgcat atcgtaaacc agcaggaaat cctgatcgga 2160
cgtaacgatg acgatggcta ttacttcaaa tttggaattt acagggtcgg taacagcacg 2220
gtcccggtta cttataacct gagcgggtac agcgaaactg ccagatag 2268
<210> 4
<211> 3420
<212> DNA
<213>artificial sequence
<220>
<223>
<400> 4
atgaaaatcg aagaaggtaa actggtaatc tggattaacg gcgataaagg ctataacggt 60
ctcgctgaag tcggtaagaa attcgagaaa gataccggaa ttaaagtcac cgttgagcat 120
ccggataaac tggaagagaa attcccacag gttgcggcaa ctggcgatgg ccctgacatt 180
atcttctggg cacacgaccg ctttggtggc tacgctcaat ctggcctgtt ggctgaaatc 240
accccggaca aagcgttcca ggacaagctg tatccgttta cctgggatgc cgtacgttac 300
aacggcaagc tgattgctta cccgatcgct gttgaagcgt tatcgctgat ttataacaaa 360
gatctgctgc cgaacccgcc aaaaacctgg gaagagatcc cggcgctgga taaagaactg 420
aaagcgaaag gtaagagcgc gctgatgttc aacctgcaag aaccgtactt cacctggccg 480
ctgattgctg ctgacggggg ttatgcgttc aagtatgaaa acggcaagta cgacattaaa 540
gacgtgggcg tggataacgc tggcgcgaaa gcgggtctga ccttcctggt tgacctgatt 600
aaaaacaaac acatgaatgc agacaccgat tactccatcg cagaagctgc ctttaataaa 660
ggcgaaacag cgatgaccat caacggcccg tgggcatggt ccaacatcga caccagcaaa 720
gtgaattatg gtgtaacggt actgccgacc ttcaagggtc aaccatccaa accgttcgtt 780
ggcgtgctga gcgcaggtat taacgccgcc agtccgaaca aagagctggc aaaagagttc 840
ctcgaaaact atctgctgac tgatgaaggt ctggaagcgg ttaataaaga caaaccgctg 900
ggtgccgtag cgctgaagtc ttacgaggaa gagttggcga aagatccacg tattgccgcc 960
actatggaaa acgcccagaa aggtgaaatc atgccgaaca tcccgcagat gtccgctttc 1020
tggtatgccg tgcgtactgc ggtgatcaac gccgccagcg gtcgtcagac tgtcgatgaa 1080
gccctgaaag acgcgcagac tgaggctgcc gcaaaggaag cggcagcgaa agaggcggcc 1140
gcaaaagagg cagcggcgaa agaagctgcg gccaagcaaa cgaaagcgga cgtcgtctgg 1200
aaagatgtcg acggcgtgag catgcctatt ccgccgaaaa cgcacccgcg tttgtatctg 1260
cgtgaacagc aagtgccgga cctgaagaat cgcatgaacg atccgaagct gaaaaaggtt 1320
tgggccgaca tgatcaaaat gcaggaagat tggaaaccgg cggacattcc ggaagttaag 1380
gattttcgct tttacttcaa tcagaaaggt ctgacggtcc gtgttgagtt gatggcactg 1440
aattatctga tgaccaagga cccgaaagtg ggtcgtgagg cgattacgag catcatcgat 1500
accctggaaa ccgcgacctt taagccagcg ggtgatatct ctcgtggcat tggtctgttt 1560
atggttacgg gcgcaatcgt ttacgactgg tgctacgacc agctgaagcc ggaagagaaa 1620
acccgtttcg tgaaagcttt tgtccgcctg gcgaagatgt tggagtgcgg ttacccaccg 1680
gttaaggata agtcgatcgt cggtcacgcg tccgagtgga tgatcatgcg tgatttgctg 1740
agcgtgggta ttgcaattta cgatgagttc ccggagatgt acaatctggc agcgggtcgc 1800
ttcttcaaag aacacctggt tgcccgtaat tggttttatc cgtcccataa ctaccaccag 1860
ggtatgagct acctgaatgt ccgttttacg aacgatttgt tcgcgctgtg gattctggac 1920
cgtatgggtg cgggtaatgt gtttaacccg ggtcaacagt tcattttgta tgacgcgatt 1980
tacaagcgtc gcccggatgg ccagattctg gcgggtggtg acgtggacta tagccgcaag 2040
aaaccgaagt actataccat gccggccttg ctggcgggta gctactataa agacgaatac 2100
ctgaactacg agtttctgaa agacccgaat gtggaaccgc attgtaagct gttcgagttc 2160
ctgtggcgcg acacccaact gggctcccgc aaacctgacg atctgccact gtcccgttat 2220
tctggcagcc cgtttggctg gatgatcgcg cgtactggct ggggtccgga atcggtgatc 2280
gcagaaatga aagtcaacga atacagcttc ctgaatcacc agcatcaaga cgctggcgct 2340
ttccagatct actacaaggg tccgctggcc attgacgccg gcagctatac gggtagcagc 2400
ggtggttata actccccgca taacaaaaac tttttcaagc gtaccattgc gcacaatagc 2460
ctgctgattt acgaccctaa agaaaccttt agcagcagcg gctacggtgg tagcgaccac 2520
acggattttg ccgcgaacga cggtggccaa cgcctgccgg gtaagggctg gattgcccct 2580
cgtgatctga aagaaatgct ggccggtgac tttcgtacgg gcaagatcct ggcgcagggc 2640
tttggtccgg ataaccaaac cccggactat acttatctga aaggcgatat taccgcagca 2700
tatagcgcaa aagtgaaaga ggtcaaacgt agctttctgt tcctgaacct gaaagacgct 2760
aaggttccgg cagcgatgat cgttttcgat aaggtggtgg catctaatcc ggacttcaag 2820
aagttctggc tgttgcatag catcgagcaa ccggagatca aaggcaacca gattactatc 2880
aaacgtacca aaaacggtga cagcggtatg ctggttaaca ccgctctgct gccagacgct 2940
gccaatagca acatcacctc tattggtggt aagggcaaag atttctgggt gtttggcacc 3000
aattacacga atgacccgaa accgggcact gatgaggcgc tggagcgtgg cgagtggcgc 3060
gtggaaatca ccccgaagaa ggcagcggca gaggactact atttgaacgt aatccaaatt 3120
gctgataata cgcagcagaa actgcacgag gtgaagcgca ttgatggtga taaagttgtc 3180
ggtgttcaac tggcggaccg catcgtcacc ttcagcaaga ccagcgaaac ggttgatcgt 3240
ccgtttggtt ttagcgtggt tggtaaaggc accttcaagt tcgtcatgac cgatctgctg 3300
ccgggcacgt ggcaagttct gaaggatggt aagatcctgt acccggcact gagcgcgaag 3360
ggcgacgatg gtccgttgta cttcgagggt accgaaggca cctatcgttt cctgcgctaa 3420
<210> 5
<211> 3084
<212> DNA
<213>artificial sequence
<220>
<223>
<400> 5
atgaaaatcg aagaaggtaa actggtaatc tggattaacg gcgataaagg ctataacggt 60
ctcgctgaag tcggtaagaa attcgagaaa gataccggaa ttaaagtcac cgttgagcat 120
ccggataaac tggaagagaa attcccacag gttgcggcaa ctggcgatgg ccctgacatt 180
atcttctggg cacacgaccg ctttggtggc tacgctcaat ctggcctgtt ggctgaaatc 240
accccggaca aagcgttcca ggacaagctg tatccgttta cctgggatgc cgtacgttac 300
aacggcaagc tgattgctta cccgatcgct gttgaagcgt tatcgctgat ttataacaaa 360
gatctgctgc cgaacccgcc aaaaacctgg gaagagatcc cggcgctgga taaagaactg 420
aaagcgaaag gtaagagcgc gctgatgttc aacctgcaag aaccgtactt cacctggccg 480
ctgattgctg ctgacggggg ttatgcgttc aagtatgaaa acggcaagta cgacattaaa 540
gacgtgggcg tggataacgc tggcgcgaaa gcgggtctga ccttcctggt tgacctgatt 600
aaaaacaaac acatgaatgc agacaccgat tactccatcg cagaagctgc ctttaataaa 660
ggcgaaacag cgatgaccat caacggcccg tgggcatggt ccaacatcga caccagcaaa 720
gtgaattatg gtgtaacggt actgccgacc ttcaagggtc aaccatccaa accgttcgtt 780
ggcgtgctga gcgcaggtat taacgccgcc agtccgaaca aagagctggc aaaagagttc 840
ctcgaaaact atctgctgac tgatgaaggt ctggaagcgg ttaataaaga caaaccgctg 900
ggtgccgtag cgctgaagtc ttacgaggaa gagttggcga aagatccacg tattgccgcc 960
actatggaaa acgcccagaa aggtgaaatc atgccgaaca tcccgcagat gtccgctttc 1020
tggtatgccg tgcgtactgc ggtgatcaac gccgccagcg gtcgtcagac tgtcgatgaa 1080
gccctgaaag acgcgcagac tgaggctgcc gcaaaggaag cggcagcgaa agaggcggcc 1140
gcaaaagagg cagcggcgaa agaagctgcg gccaagcaat ccagcagcat tactcgtaaa 1200
gacttcgacc acatcaacct ggaatatagc ggcttggaga aagtgaacaa ggcggtggcg 1260
gctggcaatt atgacgatgc cgcgaaagca ttgctggcgt actaccgcga gaaaagcaaa 1320
gcccgcgagc ctgactttag caatgctgag aagccggcag atattcgtca gccgattgat 1380
aaagtaaccc gcgaaatggc cgataaagcc ctggtccacc agttccagcc gcataaaggt 1440
tatggttatt tcgattatgg caaggatatc aactggcaga tgtggccggt caaggataac 1500
gaggttcgct ggcaactgca ccgtgtgaaa tggtggcagg caatggccct ggtctaccat 1560
gcgacgggtg acgagaaata cgctcgtgag tgggtttacc agtacagcga ctgggcgcgt 1620
aagaatccgc tgggtctgag ccaagacaat gacaagtttg tgtggcgtcc tctggaagtg 1680
agcgaccgtg tccaatctct gccgccgacg ttctccctgt tcgtcaactc cccggcattc 1740
acgccagcat tcctgatgga attcctgaac tcttaccacc agcaagcaga ctacctgagc 1800
acccattatg cggaacaagg taaccaccgt ttgttcgagg cgcaacgtaa tctgtttgcg 1860
ggcgtgagct tcccggagtt taaagacagc ccgcgttggc gtcaaaccgg catcagcgtg 1920
ctgaacaccg aaatcaagaa acaggtttat gcggatggta tgcaattcga actgagcccg 1980
atctaccatg ttgccgcgat cgacattttc ctgaaggcgt atggcagcgc caaacgtgtt 2040
aacctggaaa aagaatttcc gcagagctac gttcaaacgg ttgagaatat gatcatggct 2100
ctgatctcta ttagcctgcc ggactataac accccgatgt ttggtgactc gtggattacg 2160
gacaaaaact ttcgcatggc gcagtttgca agctgggcac gcgtctttcc ggcaaaccaa 2220
gcgatcaagt acttcgcgac cgatggtaag caaggtaaag caccgaactt cctgagcaag 2280
gcgctgagca atgcgggctt ctacaccttt cgtagcggct gggataagaa cgccactgtc 2340
atggtcctga aagcgagccc accgggtgaa ttccacgcgc agccggacaa cggtacgttc 2400
gagttgttta tcaaaggtcg caatttcact ccagatgcgg gtgtttttgt gtacagcggc 2460
gacgaggcca tcatgaagct gcgtaactgg tatcgccaga cgcgtattca ctcgaccctg 2520
accctggata atcagaatat ggtgattacc aaggcacgcc agaataagtg ggaaacgggt 2580
aacaacctgg acgtcctgac ctatacgaat ccgagctacc cgaatttgga tcaccagcgt 2640
tccgttctgt tcatcaataa gaaatacttc ttggtcattg accgtgcaat cggtgaggcg 2700
accggtaacc tgggtgttca ttggcagctg aaggaagata gcaatccggt ttttgataaa 2760
accaaaaacc gtgtttacac cacctaccgt gacggcaata acctgatgat tcagagcttg 2820
aatgctgatc gcaccagcct gaacgaggaa gagggcaaag tgtcttatgt atacaataag 2880
gagctgaagc gtccggcgtt cgtttttgag aagccaaaga agaatgcagg tacccaaaac 2940
tttgtgagca ttgtgtaccc gtatgatggt caaaaagctc cggagatttc catccgcgaa 3000
aacaaaggta acgattttga gaaaggcaag ctgaatttga ccctgacgat taatggcaag 3060
caacagttgg tcctggtgcc gtaa 3084
<210> 6
<211> 2622
<212> DNA
<213>artificial sequence
<220>
<223>
<400> 6
atgaaaatcg aagaaggtaa actggtaatc tggattaacg gcgataaagg ctataacggt 60
ctcgctgaag tcggtaagaa attcgagaaa gataccggaa ttaaagtcac cgttgagcat 120
ccggataaac tggaagagaa attcccacag gttgcggcaa ctggcgatgg ccctgacatt 180
atcttctggg cacacgaccg ctttggtggc tacgctcaat ctggcctgtt ggctgaaatc 240
accccggaca aagcgttcca ggacaagctg tatccgttta cctgggatgc cgtacgttac 300
aacggcaagc tgattgctta cccgatcgct gttgaagcgt tatcgctgat ttataacaaa 360
gatctgctgc cgaacccgcc aaaaacctgg gaagagatcc cggcgctgga taaagaactg 420
aaagcgaaag gtaagagcgc gctgatgttc aacctgcaag aaccgtactt cacctggccg 480
ctgattgctg ctgacggggg ttatgcgttc aagtatgaaa acggcaagta cgacattaaa 540
gacgtgggcg tggataacgc tggcgcgaaa gcgggtctga ccttcctggt tgacctgatt 600
aaaaacaaac acatgaatgc agacaccgat tactccatcg cagaagctgc ctttaataaa 660
ggcgaaacag cgatgaccat caacggcccg tgggcatggt ccaacatcga caccagcaaa 720
gtgaattatg gtgtaacggt actgccgacc ttcaagggtc aaccatccaa accgttcgtt 780
ggcgtgctga gcgcaggtat taacgccgcc agtccgaaca aagagctggc aaaagagttc 840
ctcgaaaact atctgctgac tgatgaaggt ctggaagcgg ttaataaaga caaaccgctg 900
ggtgccgtag cgctgaagtc ttacgaggaa gagttggcga aagatccacg tattgccgcc 960
actatggaaa acgcccagaa aggtgaaatc atgccgaaca tcccgcagat gtccgctttc 1020
tggtatgccg tgcgtactgc ggtgatcaac gccgccagcg gtcgtcagac tgtcgatgaa 1080
gccctgaaag acgcgcagac tgaggctgcc gcaaaggaag cggcagcgaa agaggcggcc 1140
gcaaaagagg cagcggcgaa agaagctgcg gccaagcagg ttgttgcttc aaatgaaact 1200
ttataccagg ttgtaaagga ggtaaaaccc ggtggtctgg tacagattgc cgatgggact 1260
tataaagatg ttcagctgat tgtcagcaat tcaggaaaat ctggtttgcc catcactatt 1320
aaagccctga acccgggtaa ggtttttttt accggagatg ctaaagtaga gctgaggggc 1380
gagcacctga tactggaagg catctggttt aaagacggga acagagctat tcaggcatgg 1440
aaatcacatg gacccggatt ggtggctata tatggtagct ataaccgcat taccgcatgt 1500
gtatttgatt gttttgatga agccaattct gcttacatta ctacttcgct taccgaagac 1560
ggaaaggtac ctcaacattg ccgcatagac cattgcagtt ttaccgataa gatcactttt 1620
gaccaggtaa ttaacctgaa caatacagcc agagctatta aagacggttc ggtgggagga 1680
ccggggatgt accatcgtgt tgatcactgt tttttttcca atccgcaaaa accgggtaat 1740
gccggagggg gaatcaggat tggctattac cgtaatgata taggccgttg tctggtagac 1800
tctaacctgt ttatgcgtca ggattcggaa gcagagatca tcaccagcaa atcgcaggaa 1860
aatgtttatt atggtaatac ttacctgaat tgccagggca ccatgaactt tcgtcacggt 1920
gatcatcagg tggccattaa caatttttat ataggcaatg accagcgatt tggatacggg 1980
ggaatgtttg tttggggaag caggcatgtc atagcctgta attattttga gctgtccgaa 2040
accataaagt cgagggggaa cgccgcattg tatttaaacc ccggtgctat ggcttcggag 2100
catgctcttg ctttcgatat gttgatagcc aacaacgctt tcatcaatgt aaatgggtat 2160
gccatccatt ttaatccatt ggatgagcgc agaaaagaat attgtgcagc caataggctt 2220
aagttcgaaa ccccgcacca gctaatgtta aaaggcaatc ttttctttaa ggataaacct 2280
tatgtttacc cattttttaa agatgattat tttatagcag ggaaaaatag ctggactggt 2340
aatgtagcct taggtgtgga aaagggaatc cctgttaaca tttcggccaa taggtctgcc 2400
tataagccgg taaaaattaa agatatccag cccatagaag gaatcgctct tgatctcaat 2460
gcgctgatca gcaaaggcat tacaggaaag ccccttagct gggatgaagt aaggccctac 2520
tggttaaaag aaatgcccgg gacgtatgct ttaacggcca ggctttctgc agatagggct 2580
gcaaagttta aagccgtaat taaaagaaat aaagagcact ga 2622
<210> 7
<211> 3216
<212> DNA
<213>artificial sequence
<220>
<223>
<400> 7
atgaaaatcg aagaaggtaa actggtaatc tggattaacg gcgataaagg ctataacggt 60
ctcgctgaag tcggtaagaa attcgagaaa gataccggaa ttaaagtcac cgttgagcat 120
ccggataaac tggaagagaa attcccacag gttgcggcaa ctggcgatgg ccctgacatt 180
atcttctggg cacacgaccg ctttggtggc tacgctcaat ctggcctgtt ggctgaaatc 240
accccggaca aagcgttcca ggacaagctg tatccgttta cctgggatgc cgtacgttac 300
aacggcaagc tgattgctta cccgatcgct gttgaagcgt tatcgctgat ttataacaaa 360
gatctgctgc cgaacccgcc aaaaacctgg gaagagatcc cggcgctgga taaagaactg 420
aaagcgaaag gtaagagcgc gctgatgttc aacctgcaag aaccgtactt cacctggccg 480
ctgattgctg ctgacggggg ttatgcgttc aagtatgaaa acggcaagta cgacattaaa 540
gacgtgggcg tggataacgc tggcgcgaaa gcgggtctga ccttcctggt tgacctgatt 600
aaaaacaaac acatgaatgc agacaccgat tactccatcg cagaagctgc ctttaataaa 660
ggcgaaacag cgatgaccat caacggcccg tgggcatggt ccaacatcga caccagcaaa 720
gtgaattatg gtgtaacggt actgccgacc ttcaagggtc aaccatccaa accgttcgtt 780
ggcgtgctga gcgcaggtat taacgccgcc agtccgaaca aagagctggc aaaagagttc 840
ctcgaaaact atctgctgac tgatgaaggt ctggaagcgg ttaataaaga caaaccgctg 900
ggtgccgtag cgctgaagtc ttacgaggaa gagttggcga aagatccacg tattgccgcc 960
actatggaaa acgcccagaa aggtgaaatc atgccgaaca tcccgcagat gtccgctttc 1020
tggtatgccg tgcgtactgc ggtgatcaac gccgccagcg gtcgtcagac tgtcgatgaa 1080
gccctgaaag acgcgcagac tgaggctgcc gcaaaggaag cggcagcgaa agaggcggcc 1140
gcaaaagagg cagcggcgaa agaagctgcg gccaagcagc agaccggtac tgcagaactg 1200
attatgaagc gggtgatgct ggaccttaaa aagcctttgc gcaatatgga taaggtggcg 1260
gaaaaggacc tgaatacgct gcagcctgac ggtagctgga aggatgtgcc ttataaagat 1320
gatgccatga ccaattggtt gccaaacaac cacctgctac aattggaaac tattatacag 1380
gcttatattg aaaaagatag tcactattat ggcgacgata aagtgtttga ccagatttcc 1440
aaagctttta agtattggta tgacagcgac ccgaaaagcc gcaactggtg gcacaatgaa 1500
attgccactc cgcaggccct tggtgaaatg ctgatcctga tgcgttacgg taaaaagccg 1560
cttgatgaag cattggtgca taaattgacc gaaagaatga agcggggcga accggagaag 1620
aaaacggggg ccaacaaaac agatatcgcc ctgcattact tttatcgtgc tttgttaacg 1680
tctgatgagg ctttgctttc cttcgccgta aaagaattgt tttatcccgt acagtttgta 1740
cactatgagg aaggcctgca atacgattat tcctacctgc agcacggtcc gcaattacag 1800
atatcgagct acggtgccgt atttattacc ggggtactga aacttgccaa ttacgttagg 1860
gatacccctt atgctttaag taccgagaaa ctggctatat tttcaaagta ttaccgcgac 1920
agttatctga aagctatccg tggaagttat atggatttta acgtagaagg ccgcggagta 1980
agccggccag acattctaaa taaaaaggca gaaaaaaaga ggttgctggt ggcgaagatg 2040
atcgatctta agcatactga agaatgggct gatgcgatag ccaggacaga tagcacagtt 2100
gcggccggct ataagattga gccctatcac catcagttct ggaatggtga ttatgtgcaa 2160
catttaagac ctgcctattc ttttaatgtt cgtatggtga gtaagcggac ccgacgcagt 2220
gaatccggca ataaagaaaa cctgctgggc aggtatttat ctgatggggc tactaacata 2280
caattgcgcg gaccagaata ctataacatt atgccggtat gggaatggga caagattcct 2340
ggcataacca gccgtgatta tttaaccgac agacctttga cgaagctttg gggagagcag 2400
gggagcaatg actttgcagg aggggtgtct gatggtgtat acggggccag tgcctacgca 2460
ttggattacg atagcttaca ggcaaagaaa gcctggttct tttttgacaa agagattgta 2520
tgtcttggtg ccggtatcaa cagcaatgcc cctgaaaaca ttaccactac ccttaaccag 2580
agctggttaa atggcccggt tataagtact gcaggtaaaa ccggccgggg taaaataaca 2640
acgtttaaag cacagggaca gttctggttg ttgcacgatg cgattggtta ttactttcct 2700
gaaggggcca accttagtct gagtacccag tcgcaaaaag gcaattggtt ccacatcaac 2760
aattcacatt caaaagatga agtttctggt gatgtattta agctttggat caaccatggt 2820
gccaggccag aaaatgcgca gtatgcttat atcgttttgc cgggaataaa caagccggaa 2880
gaaattaaaa aatataatgg aacggcaccg aaagtccttg ccaataccaa ccagctgcag 2940
gcagtttatc atcagcagtt agatatggta caggctatct tctatacagc tggaaaatta 3000
agcgtagcgg gcatagaaat tgaaacagat aagccatgtg cagtgctgat caagcacatc 3060
aatggcaagc aggtaatttg ggctgccgat ccattgcaaa aagaaaagac tgcagtgttg 3120
agcatcaggg atttaaaaac aggaaaaaca aatcgggtaa aaattgattt tccgcaacag 3180
gaatttgcag gtgcaacggt tgaactgaaa tagtaa 3216
<210> 8
<211> 2268
<212> DNA
<213>artificial sequence
<220>
<223>
<400> 8
atgaaaatcg aagaaggtaa actggtaatc tggattaacg gcgataaagg ctataacggt 60
ctcgctgaag tcggtaagaa attcgagaaa gataccggaa ttaaagtcac cgttgagcat 120
ccggataaac tggaagagaa attcccacag gttgcggcaa ctggcgatgg ccctgacatt 180
atcttctggg cacacgaccg ctttggtggc tacgctcaat ctggcctgtt ggctgaaatc 240
accccggaca aagcgttcca ggacaagctg tatccgttta cctgggatgc cgtacgttac 300
aacggcaagc tgattgctta cccgatcgct gttgaagcgt tatcgctgat ttataacaaa 360
gatctgctgc cgaacccgcc aaaaacctgg gaagagatcc cggcgctgga taaagaactg 420
aaagcgaaag gtaagagcgc gctgatgttc aacctgcaag aaccgtactt cacctggccg 480
ctgattgctg ctgacggggg ttatgcgttc aagtatgaaa acggcaagta cgacattaaa 540
gacgtgggcg tggataacgc tggcgcgaaa gcgggtctga ccttcctggt tgacctgatt 600
aaaaacaaac acatgaatgc agacaccgat tactccatcg cagaagctgc ctttaataaa 660
ggcgaaacag cgatgaccat caacggcccg tgggcatggt ccaacatcga caccagcaaa 720
gtgaattatg gtgtaacggt actgccgacc ttcaagggtc aaccatccaa accgttcgtt 780
ggcgtgctga gcgcaggtat taacgccgcc agtccgaaca aagagctggc aaaagagttc 840
ctcgaaaact atctgctgac tgatgaaggt ctggaagcgg ttaataaaga caaaccgctg 900
ggtgccgtag cgctgaagtc ttacgaggaa gagttggcga aagatccacg tattgccgcc 960
actatggaaa acgcccagaa aggtgaaatc atgccgaaca tcccgcagat gtccgctttc 1020
tggtatgccg tgcgtactgc ggtgatcaac gccgccagcg gtcgtcagac tgtcgatgaa 1080
gccctgaaag acgcgcagac tggtggtggc ggcagcggtg gcggcggtag cggcggtggt 1140
ggatccggtg gcggtggttc tggtggtggt ggcagccagc aaaaaaaatc cggtaacatc 1200
ccttaccggg taaatgtgca ggccgacagt gctaagcaga gcgagattat tgacaacaaa 1260
tgggtggcag taggcatcaa taaaccttat gcattacaat atgacgataa actgcgcttt 1320
aatggaaaac catcctatcg ctttgagctt aaagccgaag acaattcgct tgaaggttat 1380
gctgcaggag aaacaaaggg ccgtatagaa ttgtcgtaca gctatgcaac caccaatgat 1440
tttaagaaat ttcccccaag cgtataccaa aatgcgcaaa agctaaaaac cgtttatcat 1500
tacggcaaag ggatttgtga acaggggagc tcccgcagct ataccttttc agtgtacata 1560
ccctcctcct tccccgacaa tgcgactact atttttgccc aatggcatgg tgcacccagc 1620
agaacgcttg tagctacacc agagggagaa attaaaacac tgagcataga agagtttttg 1680
gccttatacg accgcatgat cttcaaaaaa aatatcgccc atgataaagt tgaaaaaaaa 1740
gataaggacg gaaaaattac ttatgtagcc ggaaagccaa atggctggaa ggtagaacaa 1800
ggtggttatc caccgctggc ctttggtttt tctaaagggt atttttacat caaggcaaac 1860
tccgaccggc agtggcttac cgacaaagcc gaccgtaaca atgccaatcc cgagaatagt 1920
gaagtaatga agccctattc ctcggaatac aaaacttcta ccattgccta taaaatgccc 1980
tttgcccagt tccctaaaga ttgctggatt acttttgatg tcgccataga ctggacgaaa 2040
tatggaaaag aggccaatac aattttgaaa cccggtaagc tggatgtgat gatgacttat 2100
accaagaata agaaaccaca aaaagcgcat atcgtaaacc agcaggaaat cctgatcgga 2160
cgtaacgatg acgatggcta ttacttcaaa tttggaattt acagggtcgg taacagcacg 2220
gtcccggtta cttataacct gagcgggtac agcgaaactg ccagatag 2268
<210> 9
<211> 3420
<212> DNA
<213>artificial sequence
<220>
<223>
<400> 9
atgaaaatcg aagaaggtaa actggtaatc tggattaacg gcgataaagg ctataacggt 60
ctcgctgaag tcggtaagaa attcgagaaa gataccggaa ttaaagtcac cgttgagcat 120
ccggataaac tggaagagaa attcccacag gttgcggcaa ctggcgatgg ccctgacatt 180
atcttctggg cacacgaccg ctttggtggc tacgctcaat ctggcctgtt ggctgaaatc 240
accccggaca aagcgttcca ggacaagctg tatccgttta cctgggatgc cgtacgttac 300
aacggcaagc tgattgctta cccgatcgct gttgaagcgt tatcgctgat ttataacaaa 360
gatctgctgc cgaacccgcc aaaaacctgg gaagagatcc cggcgctgga taaagaactg 420
aaagcgaaag gtaagagcgc gctgatgttc aacctgcaag aaccgtactt cacctggccg 480
ctgattgctg ctgacggggg ttatgcgttc aagtatgaaa acggcaagta cgacattaaa 540
gacgtgggcg tggataacgc tggcgcgaaa gcgggtctga ccttcctggt tgacctgatt 600
aaaaacaaac acatgaatgc agacaccgat tactccatcg cagaagctgc ctttaataaa 660
ggcgaaacag cgatgaccat caacggcccg tgggcatggt ccaacatcga caccagcaaa 720
gtgaattatg gtgtaacggt actgccgacc ttcaagggtc aaccatccaa accgttcgtt 780
ggcgtgctga gcgcaggtat taacgccgcc agtccgaaca aagagctggc aaaagagttc 840
ctcgaaaact atctgctgac tgatgaaggt ctggaagcgg ttaataaaga caaaccgctg 900
ggtgccgtag cgctgaagtc ttacgaggaa gagttggcga aagatccacg tattgccgcc 960
actatggaaa acgcccagaa aggtgaaatc atgccgaaca tcccgcagat gtccgctttc 1020
tggtatgccg tgcgtactgc ggtgatcaac gccgccagcg gtcgtcagac tgtcgatgaa 1080
gccctgaaag acgcgcagac tggtggtggc ggcagcggtg gcggcggtag cggcggtggt 1140
ggatccggtg gcggtggttc tggtggtggt ggcagccaaa cgaaagcgga cgtcgtctgg 1200
aaagatgtcg acggcgtgag catgcctatt ccgccgaaaa cgcacccgcg tttgtatctg 1260
cgtgaacagc aagtgccgga cctgaagaat cgcatgaacg atccgaagct gaaaaaggtt 1320
tgggccgaca tgatcaaaat gcaggaagat tggaaaccgg cggacattcc ggaagttaag 1380
gattttcgct tttacttcaa tcagaaaggt ctgacggtcc gtgttgagtt gatggcactg 1440
aattatctga tgaccaagga cccgaaagtg ggtcgtgagg cgattacgag catcatcgat 1500
accctggaaa ccgcgacctt taagccagcg ggtgatatct ctcgtggcat tggtctgttt 1560
atggttacgg gcgcaatcgt ttacgactgg tgctacgacc agctgaagcc ggaagagaaa 1620
acccgtttcg tgaaagcttt tgtccgcctg gcgaagatgt tggagtgcgg ttacccaccg 1680
gttaaggata agtcgatcgt cggtcacgcg tccgagtgga tgatcatgcg tgatttgctg 1740
agcgtgggta ttgcaattta cgatgagttc ccggagatgt acaatctggc agcgggtcgc 1800
ttcttcaaag aacacctggt tgcccgtaat tggttttatc cgtcccataa ctaccaccag 1860
ggtatgagct acctgaatgt ccgttttacg aacgatttgt tcgcgctgtg gattctggac 1920
cgtatgggtg cgggtaatgt gtttaacccg ggtcaacagt tcattttgta tgacgcgatt 1980
tacaagcgtc gcccggatgg ccagattctg gcgggtggtg acgtggacta tagccgcaag 2040
aaaccgaagt actataccat gccggccttg ctggcgggta gctactataa agacgaatac 2100
ctgaactacg agtttctgaa agacccgaat gtggaaccgc attgtaagct gttcgagttc 2160
ctgtggcgcg acacccaact gggctcccgc aaacctgacg atctgccact gtcccgttat 2220
tctggcagcc cgtttggctg gatgatcgcg cgtactggct ggggtccgga atcggtgatc 2280
gcagaaatga aagtcaacga atacagcttc ctgaatcacc agcatcaaga cgctggcgct 2340
ttccagatct actacaaggg tccgctggcc attgacgccg gcagctatac gggtagcagc 2400
ggtggttata actccccgca taacaaaaac tttttcaagc gtaccattgc gcacaatagc 2460
ctgctgattt acgaccctaa agaaaccttt agcagcagcg gctacggtgg tagcgaccac 2520
acggattttg ccgcgaacga cggtggccaa cgcctgccgg gtaagggctg gattgcccct 2580
cgtgatctga aagaaatgct ggccggtgac tttcgtacgg gcaagatcct ggcgcagggc 2640
tttggtccgg ataaccaaac cccggactat acttatctga aaggcgatat taccgcagca 2700
tatagcgcaa aagtgaaaga ggtcaaacgt agctttctgt tcctgaacct gaaagacgct 2760
aaggttccgg cagcgatgat cgttttcgat aaggtggtgg catctaatcc ggacttcaag 2820
aagttctggc tgttgcatag catcgagcaa ccggagatca aaggcaacca gattactatc 2880
aaacgtacca aaaacggtga cagcggtatg ctggttaaca ccgctctgct gccagacgct 2940
gccaatagca acatcacctc tattggtggt aagggcaaag atttctgggt gtttggcacc 3000
aattacacga atgacccgaa accgggcact gatgaggcgc tggagcgtgg cgagtggcgc 3060
gtggaaatca ccccgaagaa ggcagcggca gaggactact atttgaacgt aatccaaatt 3120
gctgataata cgcagcagaa actgcacgag gtgaagcgca ttgatggtga taaagttgtc 3180
ggtgttcaac tggcggaccg catcgtcacc ttcagcaaga ccagcgaaac ggttgatcgt 3240
ccgtttggtt ttagcgtggt tggtaaaggc accttcaagt tcgtcatgac cgatctgctg 3300
ccgggcacgt ggcaagttct gaaggatggt aagatcctgt acccggcact gagcgcgaag 3360
ggcgacgatg gtccgttgta cttcgagggt accgaaggca cctatcgttt cctgcgctaa 3420
<210> 10
<211> 3084
<212> DNA
<213>artificial sequence
<220>
<223>
<400> 10
atgaaaatcg aagaaggtaa actggtaatc tggattaacg gcgataaagg ctataacggt 60
ctcgctgaag tcggtaagaa attcgagaaa gataccggaa ttaaagtcac cgttgagcat 120
ccggataaac tggaagagaa attcccacag gttgcggcaa ctggcgatgg ccctgacatt 180
atcttctggg cacacgaccg ctttggtggc tacgctcaat ctggcctgtt ggctgaaatc 240
accccggaca aagcgttcca ggacaagctg tatccgttta cctgggatgc cgtacgttac 300
aacggcaagc tgattgctta cccgatcgct gttgaagcgt tatcgctgat ttataacaaa 360
gatctgctgc cgaacccgcc aaaaacctgg gaagagatcc cggcgctgga taaagaactg 420
aaagcgaaag gtaagagcgc gctgatgttc aacctgcaag aaccgtactt cacctggccg 480
ctgattgctg ctgacggggg ttatgcgttc aagtatgaaa acggcaagta cgacattaaa 540
gacgtgggcg tggataacgc tggcgcgaaa gcgggtctga ccttcctggt tgacctgatt 600
aaaaacaaac acatgaatgc agacaccgat tactccatcg cagaagctgc ctttaataaa 660
ggcgaaacag cgatgaccat caacggcccg tgggcatggt ccaacatcga caccagcaaa 720
gtgaattatg gtgtaacggt actgccgacc ttcaagggtc aaccatccaa accgttcgtt 780
ggcgtgctga gcgcaggtat taacgccgcc agtccgaaca aagagctggc aaaagagttc 840
ctcgaaaact atctgctgac tgatgaaggt ctggaagcgg ttaataaaga caaaccgctg 900
ggtgccgtag cgctgaagtc ttacgaggaa gagttggcga aagatccacg tattgccgcc 960
actatggaaa acgcccagaa aggtgaaatc atgccgaaca tcccgcagat gtccgctttc 1020
tggtatgccg tgcgtactgc ggtgatcaac gccgccagcg gtcgtcagac tgtcgatgaa 1080
gccctgaaag acgcgcagac tggtggtggc ggcagcggtg gcggcggtag cggcggtggt 1140
ggatccggtg gcggtggttc tggtggtggt ggcagccaat ccagcagcat tactcgtaaa 1200
gacttcgacc acatcaacct ggaatatagc ggcttggaga aagtgaacaa ggcggtggcg 1260
gctggcaatt atgacgatgc cgcgaaagca ttgctggcgt actaccgcga gaaaagcaaa 1320
gcccgcgagc ctgactttag caatgctgag aagccggcag atattcgtca gccgattgat 1380
aaagtaaccc gcgaaatggc cgataaagcc ctggtccacc agttccagcc gcataaaggt 1440
tatggttatt tcgattatgg caaggatatc aactggcaga tgtggccggt caaggataac 1500
gaggttcgct ggcaactgca ccgtgtgaaa tggtggcagg caatggccct ggtctaccat 1560
gcgacgggtg acgagaaata cgctcgtgag tgggtttacc agtacagcga ctgggcgcgt 1620
aagaatccgc tgggtctgag ccaagacaat gacaagtttg tgtggcgtcc tctggaagtg 1680
agcgaccgtg tccaatctct gccgccgacg ttctccctgt tcgtcaactc cccggcattc 1740
acgccagcat tcctgatgga attcctgaac tcttaccacc agcaagcaga ctacctgagc 1800
acccattatg cggaacaagg taaccaccgt ttgttcgagg cgcaacgtaa tctgtttgcg 1860
ggcgtgagct tcccggagtt taaagacagc ccgcgttggc gtcaaaccgg catcagcgtg 1920
ctgaacaccg aaatcaagaa acaggtttat gcggatggta tgcaattcga actgagcccg 1980
atctaccatg ttgccgcgat cgacattttc ctgaaggcgt atggcagcgc caaacgtgtt 2040
aacctggaaa aagaatttcc gcagagctac gttcaaacgg ttgagaatat gatcatggct 2100
ctgatctcta ttagcctgcc ggactataac accccgatgt ttggtgactc gtggattacg 2160
gacaaaaact ttcgcatggc gcagtttgca agctgggcac gcgtctttcc ggcaaaccaa 2220
gcgatcaagt acttcgcgac cgatggtaag caaggtaaag caccgaactt cctgagcaag 2280
gcgctgagca atgcgggctt ctacaccttt cgtagcggct gggataagaa cgccactgtc 2340
atggtcctga aagcgagccc accgggtgaa ttccacgcgc agccggacaa cggtacgttc 2400
gagttgttta tcaaaggtcg caatttcact ccagatgcgg gtgtttttgt gtacagcggc 2460
gacgaggcca tcatgaagct gcgtaactgg tatcgccaga cgcgtattca ctcgaccctg 2520
accctggata atcagaatat ggtgattacc aaggcacgcc agaataagtg ggaaacgggt 2580
aacaacctgg acgtcctgac ctatacgaat ccgagctacc cgaatttgga tcaccagcgt 2640
tccgttctgt tcatcaataa gaaatacttc ttggtcattg accgtgcaat cggtgaggcg 2700
accggtaacc tgggtgttca ttggcagctg aaggaagata gcaatccggt ttttgataaa 2760
accaaaaacc gtgtttacac cacctaccgt gacggcaata acctgatgat tcagagcttg 2820
aatgctgatc gcaccagcct gaacgaggaa gagggcaaag tgtcttatgt atacaataag 2880
gagctgaagc gtccggcgtt cgtttttgag aagccaaaga agaatgcagg tacccaaaac 2940
tttgtgagca ttgtgtaccc gtatgatggt caaaaagctc cggagatttc catccgcgaa 3000
aacaaaggta acgattttga gaaaggcaag ctgaatttga ccctgacgat taatggcaag 3060
caacagttgg tcctggtgcc gtaa 3084
<210> 11
<211> 2622
<212> DNA
<213>artificial sequence
<220>
<223>
<400> 11
atgaaaatcg aagaaggtaa actggtaatc tggattaacg gcgataaagg ctataacggt 60
ctcgctgaag tcggtaagaa attcgagaaa gataccggaa ttaaagtcac cgttgagcat 120
ccggataaac tggaagagaa attcccacag gttgcggcaa ctggcgatgg ccctgacatt 180
atcttctggg cacacgaccg ctttggtggc tacgctcaat ctggcctgtt ggctgaaatc 240
accccggaca aagcgttcca ggacaagctg tatccgttta cctgggatgc cgtacgttac 300
aacggcaagc tgattgctta cccgatcgct gttgaagcgt tatcgctgat ttataacaaa 360
gatctgctgc cgaacccgcc aaaaacctgg gaagagatcc cggcgctgga taaagaactg 420
aaagcgaaag gtaagagcgc gctgatgttc aacctgcaag aaccgtactt cacctggccg 480
ctgattgctg ctgacggggg ttatgcgttc aagtatgaaa acggcaagta cgacattaaa 540
gacgtgggcg tggataacgc tggcgcgaaa gcgggtctga ccttcctggt tgacctgatt 600
aaaaacaaac acatgaatgc agacaccgat tactccatcg cagaagctgc ctttaataaa 660
ggcgaaacag cgatgaccat caacggcccg tgggcatggt ccaacatcga caccagcaaa 720
gtgaattatg gtgtaacggt actgccgacc ttcaagggtc aaccatccaa accgttcgtt 780
ggcgtgctga gcgcaggtat taacgccgcc agtccgaaca aagagctggc aaaagagttc 840
ctcgaaaact atctgctgac tgatgaaggt ctggaagcgg ttaataaaga caaaccgctg 900
ggtgccgtag cgctgaagtc ttacgaggaa gagttggcga aagatccacg tattgccgcc 960
actatggaaa acgcccagaa aggtgaaatc atgccgaaca tcccgcagat gtccgctttc 1020
tggtatgccg tgcgtactgc ggtgatcaac gccgccagcg gtcgtcagac tgtcgatgaa 1080
gccctgaaag acgcgcagac tggtggtggc ggcagcggtg gcggcggtag cggcggtggt 1140
ggatccggtg gcggtggttc tggtggtggt ggcagccagg ttgttgcttc aaatgaaact 1200
ttataccagg ttgtaaagga ggtaaaaccc ggtggtctgg tacagattgc cgatgggact 1260
tataaagatg ttcagctgat tgtcagcaat tcaggaaaat ctggtttgcc catcactatt 1320
aaagccctga acccgggtaa ggtttttttt accggagatg ctaaagtaga gctgaggggc 1380
gagcacctga tactggaagg catctggttt aaagacggga acagagctat tcaggcatgg 1440
aaatcacatg gacccggatt ggtggctata tatggtagct ataaccgcat taccgcatgt 1500
gtatttgatt gttttgatga agccaattct gcttacatta ctacttcgct taccgaagac 1560
ggaaaggtac ctcaacattg ccgcatagac cattgcagtt ttaccgataa gatcactttt 1620
gaccaggtaa ttaacctgaa caatacagcc agagctatta aagacggttc ggtgggagga 1680
ccggggatgt accatcgtgt tgatcactgt tttttttcca atccgcaaaa accgggtaat 1740
gccggagggg gaatcaggat tggctattac cgtaatgata taggccgttg tctggtagac 1800
tctaacctgt ttatgcgtca ggattcggaa gcagagatca tcaccagcaa atcgcaggaa 1860
aatgtttatt atggtaatac ttacctgaat tgccagggca ccatgaactt tcgtcacggt 1920
gatcatcagg tggccattaa caatttttat ataggcaatg accagcgatt tggatacggg 1980
ggaatgtttg tttggggaag caggcatgtc atagcctgta attattttga gctgtccgaa 2040
accataaagt cgagggggaa cgccgcattg tatttaaacc ccggtgctat ggcttcggag 2100
catgctcttg ctttcgatat gttgatagcc aacaacgctt tcatcaatgt aaatgggtat 2160
gccatccatt ttaatccatt ggatgagcgc agaaaagaat attgtgcagc caataggctt 2220
aagttcgaaa ccccgcacca gctaatgtta aaaggcaatc ttttctttaa ggataaacct 2280
tatgtttacc cattttttaa agatgattat tttatagcag ggaaaaatag ctggactggt 2340
aatgtagcct taggtgtgga aaagggaatc cctgttaaca tttcggccaa taggtctgcc 2400
tataagccgg taaaaattaa agatatccag cccatagaag gaatcgctct tgatctcaat 2460
gcgctgatca gcaaaggcat tacaggaaag ccccttagct gggatgaagt aaggccctac 2520
tggttaaaag aaatgcccgg gacgtatgct ttaacggcca ggctttctgc agatagggct 2580
gcaaagttta aagccgtaat taaaagaaat aaagagcact ga 2622
<210> 12
<211> 3216
<212> DNA
<213>artificial sequence
<220>
<223>
<400> 12
atgaaaatcg aagaaggtaa actggtaatc tggattaacg gcgataaagg ctataacggt 60
ctcgctgaag tcggtaagaa attcgagaaa gataccggaa ttaaagtcac cgttgagcat 120
ccggataaac tggaagagaa attcccacag gttgcggcaa ctggcgatgg ccctgacatt 180
atcttctggg cacacgaccg ctttggtggc tacgctcaat ctggcctgtt ggctgaaatc 240
accccggaca aagcgttcca ggacaagctg tatccgttta cctgggatgc cgtacgttac 300
aacggcaagc tgattgctta cccgatcgct gttgaagcgt tatcgctgat ttataacaaa 360
gatctgctgc cgaacccgcc aaaaacctgg gaagagatcc cggcgctgga taaagaactg 420
aaagcgaaag gtaagagcgc gctgatgttc aacctgcaag aaccgtactt cacctggccg 480
ctgattgctg ctgacggggg ttatgcgttc aagtatgaaa acggcaagta cgacattaaa 540
gacgtgggcg tggataacgc tggcgcgaaa gcgggtctga ccttcctggt tgacctgatt 600
aaaaacaaac acatgaatgc agacaccgat tactccatcg cagaagctgc ctttaataaa 660
ggcgaaacag cgatgaccat caacggcccg tgggcatggt ccaacatcga caccagcaaa 720
gtgaattatg gtgtaacggt actgccgacc ttcaagggtc aaccatccaa accgttcgtt 780
ggcgtgctga gcgcaggtat taacgccgcc agtccgaaca aagagctggc aaaagagttc 840
ctcgaaaact atctgctgac tgatgaaggt ctggaagcgg ttaataaaga caaaccgctg 900
ggtgccgtag cgctgaagtc ttacgaggaa gagttggcga aagatccacg tattgccgcc 960
actatggaaa acgcccagaa aggtgaaatc atgccgaaca tcccgcagat gtccgctttc 1020
tggtatgccg tgcgtactgc ggtgatcaac gccgccagcg gtcgtcagac tgtcgatgaa 1080
gccctgaaag acgcgcagac tggtggtggc ggcagcggtg gcggcggtag cggcggtggt 1140
ggatccggtg gcggtggttc tggtggtggt ggcagccagc agaccggtac tgcagaactg 1200
attatgaagc gggtgatgct ggaccttaaa aagcctttgc gcaatatgga taaggtggcg 1260
gaaaaggacc tgaatacgct gcagcctgac ggtagctgga aggatgtgcc ttataaagat 1320
gatgccatga ccaattggtt gccaaacaac cacctgctac aattggaaac tattatacag 1380
gcttatattg aaaaagatag tcactattat ggcgacgata aagtgtttga ccagatttcc 1440
aaagctttta agtattggta tgacagcgac ccgaaaagcc gcaactggtg gcacaatgaa 1500
attgccactc cgcaggccct tggtgaaatg ctgatcctga tgcgttacgg taaaaagccg 1560
cttgatgaag cattggtgca taaattgacc gaaagaatga agcggggcga accggagaag 1620
aaaacggggg ccaacaaaac agatatcgcc ctgcattact tttatcgtgc tttgttaacg 1680
tctgatgagg ctttgctttc cttcgccgta aaagaattgt tttatcccgt acagtttgta 1740
cactatgagg aaggcctgca atacgattat tcctacctgc agcacggtcc gcaattacag 1800
atatcgagct acggtgccgt atttattacc ggggtactga aacttgccaa ttacgttagg 1860
gatacccctt atgctttaag taccgagaaa ctggctatat tttcaaagta ttaccgcgac 1920
agttatctga aagctatccg tggaagttat atggatttta acgtagaagg ccgcggagta 1980
agccggccag acattctaaa taaaaaggca gaaaaaaaga ggttgctggt ggcgaagatg 2040
atcgatctta agcatactga agaatgggct gatgcgatag ccaggacaga tagcacagtt 2100
gcggccggct ataagattga gccctatcac catcagttct ggaatggtga ttatgtgcaa 2160
catttaagac ctgcctattc ttttaatgtt cgtatggtga gtaagcggac ccgacgcagt 2220
gaatccggca ataaagaaaa cctgctgggc aggtatttat ctgatggggc tactaacata 2280
caattgcgcg gaccagaata ctataacatt atgccggtat gggaatggga caagattcct 2340
ggcataacca gccgtgatta tttaaccgac agacctttga cgaagctttg gggagagcag 2400
gggagcaatg actttgcagg aggggtgtct gatggtgtat acggggccag tgcctacgca 2460
ttggattacg atagcttaca ggcaaagaaa gcctggttct tttttgacaa agagattgta 2520
tgtcttggtg ccggtatcaa cagcaatgcc cctgaaaaca ttaccactac ccttaaccag 2580
agctggttaa atggcccggt tataagtact gcaggtaaaa ccggccgggg taaaataaca 2640
acgtttaaag cacagggaca gttctggttg ttgcacgatg cgattggtta ttactttcct 2700
gaaggggcca accttagtct gagtacccag tcgcaaaaag gcaattggtt ccacatcaac 2760
aattcacatt caaaagatga agtttctggt gatgtattta agctttggat caaccatggt 2820
gccaggccag aaaatgcgca gtatgcttat atcgttttgc cgggaataaa caagccggaa 2880
gaaattaaaa aatataatgg aacggcaccg aaagtccttg ccaataccaa ccagctgcag 2940
gcagtttatc atcagcagtt agatatggta caggctatct tctatacagc tggaaaatta 3000
agcgtagcgg gcatagaaat tgaaacagat aagccatgtg cagtgctgat caagcacatc 3060
aatggcaagc aggtaatttg ggctgccgat ccattgcaaa aagaaaagac tgcagtgttg 3120
agcatcaggg atttaaaaac aggaaaaaca aatcgggtaa aaattgattt tccgcaacag 3180
gaatttgcag gtgcaacggt tgaactgaaa tagtaa 3216
Claims (4)
1. a kind of MBP fusion heparinase containing link peptide SEQ ID NO.1 merges heparin selected from MBP fusion heparinase I, MBP
Enzyme II, MBP fusion heparinase III, nucleotide sequence are respectively SEQ ID NO.3, SEQ ID NO.4, SEQ ID in sequence table
NO.5。
2. a kind of MBP containing link peptide SEQ ID NO.1 merges chondrosulphatase, chondrosulphatase is merged selected from MBP
B, MBP merges chondrosulphatase AC, and nucleotide sequence is respectively SEQ ID NO.6 in sequence table, SEQ ID NO.7.
3. a kind of MBP fusion heparinase containing link peptide SEQ ID NO.2 merges heparin selected from MBP fusion heparinase I, MBP
Enzyme II, MBP fusion heparinase III, nucleotide sequence are respectively SEQ ID NO.8, SEQ ID NO.9, SEQ ID in sequence table
NO.10。
4. a kind of MBP containing link peptide SEQ ID NO.2 merges chondrosulphatase, chondrosulphatase is merged selected from MBP
B, MBP merges chondrosulphatase AC, and nucleotide sequence is respectively SEQ ID NO.11 in sequence table, SEQ ID NO.12.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410769966.1A CN105753945B (en) | 2014-12-15 | 2014-12-15 | A kind of link peptide and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410769966.1A CN105753945B (en) | 2014-12-15 | 2014-12-15 | A kind of link peptide and its application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105753945A CN105753945A (en) | 2016-07-13 |
CN105753945B true CN105753945B (en) | 2019-04-09 |
Family
ID=56336296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410769966.1A Active CN105753945B (en) | 2014-12-15 | 2014-12-15 | A kind of link peptide and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105753945B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11123438B2 (en) | 2016-08-19 | 2021-09-21 | Ampsource Biopharma Shanghai Inc. | Linker peptide for constructing fusion protein |
CN106279437B (en) | 2016-08-19 | 2017-10-31 | 安源医药科技(上海)有限公司 | Hyperglycosylated human coagulation factor VIII fusion proteins and preparation method thereof and purposes |
CN107759697B (en) * | 2016-08-19 | 2023-03-24 | 安源医药科技(上海)有限公司 | Method for producing fusion protein |
CN112574286A (en) * | 2020-01-02 | 2021-03-30 | 东莞市东阳光生物药研发有限公司 | Polypeptide and application thereof |
US11981718B2 (en) | 2020-05-27 | 2024-05-14 | Ampsource Biopharma Shanghai Inc. | Dual-function protein for lipid and blood glucose regulation |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1699424A (en) * | 2004-05-19 | 2005-11-23 | 清华大学 | Heparinase I fusion protein and genes encoding same and expression method thereof |
CN101942024A (en) * | 2010-08-20 | 2011-01-12 | 清华大学 | Heparanase II fusion protein and coding gene and expression method thereof |
CN101942025A (en) * | 2010-08-20 | 2011-01-12 | 清华大学 | Heparanase III fusion protein and coding gene and expression method thereof |
TW201122110A (en) * | 2009-12-18 | 2011-07-01 | Univ Nat Chiao Tung | Vectors, methods, systems and kits for protein purification |
CN103103173A (en) * | 2011-11-11 | 2013-05-15 | 清华大学 | Chondrosulphatase B fusion protein, and coding gene and construction method thereof |
CN103103174A (en) * | 2011-11-11 | 2013-05-15 | 清华大学 | Chondrosulphatase AC fusion protein, and coding gene and construction method thereof |
CN103180339A (en) * | 2010-05-26 | 2013-06-26 | 百时美施贵宝公司 | Fibronectin based scaffold proteins having improved stability |
-
2014
- 2014-12-15 CN CN201410769966.1A patent/CN105753945B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1699424A (en) * | 2004-05-19 | 2005-11-23 | 清华大学 | Heparinase I fusion protein and genes encoding same and expression method thereof |
TW201122110A (en) * | 2009-12-18 | 2011-07-01 | Univ Nat Chiao Tung | Vectors, methods, systems and kits for protein purification |
CN103180339A (en) * | 2010-05-26 | 2013-06-26 | 百时美施贵宝公司 | Fibronectin based scaffold proteins having improved stability |
CN101942024A (en) * | 2010-08-20 | 2011-01-12 | 清华大学 | Heparanase II fusion protein and coding gene and expression method thereof |
CN101942025A (en) * | 2010-08-20 | 2011-01-12 | 清华大学 | Heparanase III fusion protein and coding gene and expression method thereof |
CN103103173A (en) * | 2011-11-11 | 2013-05-15 | 清华大学 | Chondrosulphatase B fusion protein, and coding gene and construction method thereof |
CN103103174A (en) * | 2011-11-11 | 2013-05-15 | 清华大学 | Chondrosulphatase AC fusion protein, and coding gene and construction method thereof |
Non-Patent Citations (3)
Title |
---|
MBP 融合肝素酶Ⅲ大肠杆菌高效表达体系构建;苏楠 等;《化工学报》;20140731;第65卷(第7期);第2830页左栏第1段 |
多功能融合肝素酶的设计及其制备低分子量肝素工艺;叶逢春;《中国博士学位论文全文数据库 工程科技Ⅰ辑》;20130915(第09(2013)期);B016-66 |
融合酶的设计和应用研究进展;黄子亮 等;《生物工程学报》;20120425;第28卷(第4期);第397页右栏,第398页左栏第1段,第401页右栏第2段-第402页左栏第1段 |
Also Published As
Publication number | Publication date |
---|---|
CN105753945A (en) | 2016-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105753945B (en) | A kind of link peptide and its application | |
JP5393481B2 (en) | Chondroitin-producing bacteria and method for producing chondroitin | |
Foran et al. | Functional characterization of a novel “ulvan utilization loci” found in Alteromonas sp. LOR genome | |
PH12015500661B1 (en) | Glucosyltransferase enzymes for production of glucan polymers | |
KR20180030536A (en) | Novel endos mutant enzyme | |
JP2004208684A5 (en) | ||
WO2016063261A1 (en) | Mutated fucosidase | |
CN109321549B (en) | Directional modification enzyme of heparinase I with improved specific enzyme activity, molecular modification method and expression engineering bacteria | |
Duncan et al. | Characterization of the N-deacetylase domain from the heparan sulfate N-deacetylase/N-sulfotransferase 2 | |
CN110468114A (en) | A kind of polyphosphate kinase RmPPK and its encoding gene and application | |
WO2004017910A2 (en) | Total synthesis of heparin | |
CN110777140B (en) | Chondrosulphatase AC mutant and preparation method thereof | |
CN108531470B (en) | Fucoidin lyase TFLFM and preparation method and application thereof | |
Filipe et al. | Functional analysis of Streptococcus pneumoniae MurM reveals the region responsible for its specificity in the synthesis of branched cell wall peptides | |
JP6451119B2 (en) | Method for separating antibodies based on the strength of antibody-dependent cytotoxic activity | |
CN109666666B (en) | Mutant for improving heat stability of heparinase I through enzyme flexible analysis based on molecular dynamics and preparation method thereof | |
RU2650667C1 (en) | Mutant recombinant heparinase i with increased specific activity from pedobacter heparinus, dna fragment that codes the said heparinase | |
US8026090B2 (en) | Modified chondroitin synthase polypeptide and crystal thereof | |
Vallet et al. | Functional and structural insights into human N‐deacetylase/N‐sulfotransferase activities | |
CN111304186A (en) | Construction method of high-catalytic-activity heparin C5 isomerase strain | |
Chu et al. | Functional characterization of a novel oligoalginate lyase of Stenotrophomonas maltophilia KJ-2 using site-specific mutation reveals bifunctional mode of action, possessing both endolytic and exolytic degradation activity toward alginate in seaweed biomass | |
JP4791676B2 (en) | Sulfate transferase and DNA encoding the enzyme | |
CN113564135B (en) | Lyase monooxygenase mutant with improved enzyme activity and stability, genetically engineered bacterium and application | |
CN113186215B (en) | High-activity and high-heat-stability heparinase I derived from bacteroides and application thereof | |
Zhang et al. | The role of the diphthamide-containing loop within eukaryotic elongation factor 2 in ADP-ribosylation by Pseudomonas aeruginosa exotoxin A |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |